Ogul, A. Et Al. 2021. Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers. JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.1 , 294-299.

Ogul, A., Kidi, M. M., & Buyuksimsek, M., (2021). Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers. JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.1, 294-299.

Ogul, ALİ, Mehmet Mutlu Kidi, And MAHMUT BÜYÜKŞİMŞEK. "Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers," JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.1, 294-299, 2021

Ogul, ALİ Et Al. "Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers." JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.1, pp.294-299, 2021

Ogul, A. Kidi, M. M. And Buyuksimsek, M. (2021) . "Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers." JOURNAL OF GASTROINTESTINAL CANCER , vol.52, no.1, pp.294-299.

@article{article, author={ALİ OĞUL Et Al. }, title={Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers}, journal={JOURNAL OF GASTROINTESTINAL CANCER}, year=2021, pages={294-299} }